Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaokeqing granule is a Traditional Chinese Medicine (TCM) herbal formulation developed by The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine. It is currently under clinical investigation for the management of prediabetes and the prevention of progression to type 2 diabetes mellitus. The granule is designed to improve glycemic parameters, including fasting blood glucose, postprandial blood glucose, and HbA1c, while also addressing traditional Chinese medicine syndrome scores related to "Xiaoke" (wasting-thirst syndrome). As a TCM preparation, it likely exerts its therapeutic effects through a multi-component approach to modulate glucose metabolism and insulin sensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaokeqing granule.